BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma.

CONCLUSIONS This retrospective study based on real-world data introduces the option of substituting carmustine with cisplatin+dexamethasone, with a similar response, expected lower cost, and better accessibility in developing nations. PMID: 31636248 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31636248?dopt=Abstract

Source: Annals of Transplantation - October 21, 2019 Category: Transplant Surgery Authors: Ron-Magaña AL, Fernandez-Vargas OE, Barrera-Chairez E, Ron-Guerrero CS, Bañuelos-Ávila AJ Tags: Ann Transplant Source Type: research